Max Healthcare Institute Ltd carries a market capitalization of 1.10T, placing it among publicly traded companies globally. Its enterprise value stands at 961.63B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.10T |
| Enterprise Value | 961.63B |
Max Healthcare Institute Ltd currently has 973.19M shares outstanding.
| Shares Outstanding | 973.19M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Max Healthcare Institute Ltd trades at a trailing price-to-earnings ratio of 64.79. The price-to-sales ratio is 11.16, and the price-to-book ratio stands at 96.04.
| PE Ratio | 64.79 |
| PS Ratio | 11.16 |
| PB Ratio | 96.04 |
| P/TBV Ratio | 19.72 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Max Healthcare Institute Ltd trades at an EV/EBITDA multiple of 53.53 and an EV/FCF ratio of 475.15. The EV/Sales ratio of 11.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 53.53 provides insight into valuation relative to core operating earnings.
| EV / Sales | 11.48 |
| EV / EBITDA | 53.53 |
| EV / EBIT | 53.53 |
| EV / FCF | 475.15 |
Max Healthcare Institute Ltd maintains a current ratio of 0.89, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.37, indicating elevated leverage, while an interest coverage ratio of 7.64 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 0.89 |
| Quick Ratio | 0.35 |
| Debt / Equity | 32.37 |
| Debt / EBITDA | 1.94 |
| Interest Coverage | 7.64 |
Max Healthcare Institute Ltd posts a return on equity of 57.05 and a return on invested capital of 11.64.
| Return on Equity (ROE) | 57.05 |
| Return on Assets (ROA) | 8.89 |
| Return on Invested Capital (ROIC) | 11.64 |
| Return on Capital Employed (ROCE) | 28.49 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 16.24 |
Over the trailing twelve months, Max Healthcare Institute Ltd has paid 2.33B in income taxes, reflecting an effective tax rate of 13.92.
| Income Tax | 2.33B |
| Effective Tax Rate | 13.92 |
Max Healthcare Institute Ltd's stock has declined approximately -12.86687% over the past 52 weeks. The 50-day moving average sits at 1,036.35, while the 200-day moving average is 1,059.69.
| Beta (5Y) | N/A |
| 52-Week Price Change | -12.86687% |
| 50-Day Moving Average | 1,036.35 |
| 200-Day Moving Average | 1,059.69 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Max Healthcare Institute Ltd generated 83.73B in revenue and converted that into 14.42B in net income, yielding earnings per share of 14.76. EBITDA reached 17.96B, while operating income came in at 17.96B.
| Revenue | 83.73B |
| Gross Profit | 65.83B |
| Operating Income | 17.96B |
| Pretax Income | 16.76B |
| Net Income | 14.42B |
| EBITDA | 17.96B |
| EBIT | 17.96B |
| Earnings Per Share (EPS) | 14.76 |
Max Healthcare Institute Ltd holds 7.71B in cash and equivalents against 34.78B in total debt, resulting in a net debt position of 22.41B. Total book value stands at 9.73B, with working capital of -2.42B providing operational flexibility.
| Cash & Cash Equivalents | 7.71B |
| Total Debt | 34.78B |
| Net Debt | 22.41B |
| Equity (Book Value) | 9.73B |
| Book Value Per Share | 10.01 |
| Working Capital | -2.42B |
Max Healthcare Institute Ltd operates with a gross margin of 78.62, reflecting its pricing power and cost economics. The operating margin of 21.45 and net profit margin of 17.23 provide insight into operational efficiency.
| Gross Margin | 78.62 |
| Operating Margin | 21.45 |
| Pretax Margin | 20.01 |
| Profit Margin | 17.23 |
| EBITDA Margin | 21.45 |
Max Healthcare Institute Ltd posts an Altman Z-Score of 9.90, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 9.90 |